Despite ongoing research, there are still many questions about the diagnosis and treatment of Pernicious Anaemia that remain unanswered.
It is important for research funders to understand what is important to patients, carers and vascular health professionals so they can focus their research on areas that will make the biggest difference.
The Pernicious Anaemia James Lind Alliance Priority Setting Partnership (PSP) will also help to increase awareness of why research into Pernicious Anaemia is necessary and important.
The project is being independently overseen by The James Lind Alliance. The James Lind Alliance is a charity set up by the National Institute for Health Research in 2004. Its purpose is to bring together patients and patient groups, clinicians and other health related researchers to identify ‘uncertainties’ relating to the diagnosis and treatment of diseases. The JLA was established because it was thought that too many research programmes, funded by the National Institute for Health Research, were for the benefit of clinicians and other scientists and there was little or no opportunity for patients to have an input into the process that identifies ‘uncertainties’ that need researching. The JLA allows patients and clinicians the opportunity to agree on research topics that deserve to be researched.
The James Lind Alliance (JLA) facilitates the formation of a Priority Setting Partnership (PSP) that is composed of patients, clinicians and health related researchers. The PSP is the body that brings together patients and researchers to agree on topics that need to be researched. The PSP considers the results of a survey of patients who were asked to identify twenty uncertainties relating to the diagnosis and treatment of Pernicious Anaemia. Eventually, after much discussion and after various stages have been completed, the twenty uncertainties are whittled down to the ten most important questions that patients would like answered.